While the pharmacokinetic curve follows the same mathematical principles as semaglutide and tirzepatide, the clinical experience of that curve can feel quite different
PMID: 25034542
Future FDA-approved access: If approval happens, the pricing model will likely shift again toward branded pricing, insurance rules, copays, prior authorization, and retail or specialty pharmacy dispensing
Not recommended for pregnant or breastfeeding women, adolescents or people on medication
You may have heard of semaglutide, often marketed as Ozempic and Wegovy, as a medication for type 2 diabetes and weight management
The peptide promotes fatty acid oxidation in skeletal muscle, enhancing the utilization of lipids as an energy source while sparing glucose for other metabolic processes